Life Expectancy of Transplanted Livers - HOPE Against Aging?
Status Publisher Jazyk angličtina Země Spojené státy americké Médium print-electronic
Typ dokumentu časopisecké články
PubMed
40772946
DOI
10.1097/sla.0000000000006883
PII: 00000658-990000000-01418
Knihovny.cz E-zdroje
- Klíčová slova
- cumulative liver age, liver transplantation, machine liver perfusion,
- Publikační typ
- časopisecké články MeSH
OBJECTIVE: To investigate the impact of cumulative liver age on graft survival in liver transplant recipients. SUMMARY OF BACKGROUND DATA: Organ shortage has led to increased use of elderly donor livers for an ageing group of recipients, particularly in Europe. We hypothesized that hypothermic oxygenated perfusion (HOPE) enhances graft resilience against aging in livers from elderly donors. METHODS: This post-hoc analysis of the multicenter European HOPE-REAL study (NCT05520320) examined liver age in adult recipients of HOPE-treated brain-dead donor (DBD) livers. Cumulative liver age was defined as the sum of donor age and post-transplant graft survival. HOPE-treated DBD liver transplants were compared with a single-center control cohort of non-perfused DBD livers using propensity score matching to adjust for confounders. RESULTS: The median cumulative liver age was significantly higher in the HOPE-treated (n=768) cohort than in the non-perfused (n=863) group (69 vs. 61 years, P<0.001), yet graft survival was superior in the HOPE-treated group (log-rank P<0.001). After matching, cumulative liver age remained significantly higher in the HOPE group (P<0.001). Multivariate analysis identified HOPE as an independent predictor of cumulative liver age (P<0.001). CONCLUSIONS: HOPE treatment appears to mitigate the risks associated with transplanting elderly DBD livers, leading to excellent long-term survival in an ageing recipient population. These findings support broader adoption of HOPE to improve utilization of older donor livers and expand the donor pool.
CHU Rennes Service de Chirurgie Hépatobiliaire et Digestive Rennes France
Department of Organ Failure and Transplantation ASST Papa Giovanni XXIII Bergamo Italy
Department of Surgery Universitätsklinikum Heidelberg Heidelberg Germany
Department of Transplant Surgery University of Munich Grosshadern Gemany
Department of Visceral Surgery University of Basel Clarunis Basel Switzerland
Department of Visceral Transplantation University Medical Center Hamburg Eppendorf Hamburg Germany
Division of Transplantation Medical University of Vienna Vienna Austria
Transplant Institute Sahlgrenska University Hospital Gothenburg Sweden
Transplant Surgery Department Institute for Clinical and Experimental Medicine Prague Czech Republic
UMCG Comprehensive Transplant Center Groningen the Netherlands
Citace poskytuje Crossref.org